Differential expression of colorectal neoplasia expressed (CRNDE) is positively correlated with tumor immunity, as it can increase the expression of immune checkpoints such as CD274 (PDL1), PDCD1LG2 (PD-L2), CD86, and CD276. Here, PDCD1LG2 is linked to neoplasm.